News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

New Study Reveals Economic Ripple Effects of Mass Shootings on Local Businesses
News Release

BALTIMORE, MD, May 13, 2025 – As communities across the United States continue to confront the devastating toll of mass shootings, new research reveals a staggering economic dimension to these tragedies. A study published in the INFORMS journal Marketing Science finds that mass shootings cause an estimated $27 billion in annual lost revenue for U.S. retailers driven by sharp declines in foot traffic, reduced transaction volume and long-term store closures.

Read More
New Research Reveals Concealed Carry ‘Shall Issue’ Laws Increase Handgun Purchases, While ‘Permitless Carry’ Shows No Effect
News Release

BALTIMORE, MD, May 13, 2025 – Researchers who took a close look at loosened concealed carry laws between 2010 and 2017 have found that “Shall Issue” regulations, which remove local authority discretion on the issuance of concealed carry gun permits, contribute to a significant increase in handgun purchases. At the same time, the researchers found that in states that adopted “Permitless Carry” policies, there was no noticeable change in gun purchases.

Read More
Can You Fly Without a REAL ID After May 7 Deadline? What To Know
Media Coverage

The time has come: REAL ID will finally be implemented in less than one week, about 20 years after it was initially proposed.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
States Craft Vaccine Plans in a Haze of Changing Information

States Craft Vaccine Plans in a Haze of Changing Information

Bloomberg, December 4, 2020

Weeks before states expect to receive their first shipments of Covid-19 vaccines, conflicting messages from the federal government have obscured exactly how many doses may arrive. Some governors, including New York’s Andrew Cuomo and California’s Gavin Newsom, have made splashy announcements about how much of Pfizer Inc. and BioNTech SE’s vaccines they expect should the U.S. Food and Drug Administration authorize them this month. Other states can’t provide a solid answer given how quickly estimates change

Minnesota-Based Company Will Protect COVID-19 Vaccines on Supply Chains

Minnesota-Based Company Will Protect COVID-19 Vaccines on Supply Chains

Kare, December 3, 2020

Shortly before World War II, Minnesota-based U.S. Thermo Control Company introduced the revolutionary concept of transport refrigeration to the world, allowing trucks to haul frozen foods and perishables to every corner of the United States. The company, co-founded by renowned inventor Frederick McKinley Jones and businessman Joseph Numero, helped store items at controlled temperatures as they crossed “through mountain blizzards and desert heat,” according to a May 1950 article in the Minneapolis Sunday Tribune. During the war, these refrigeration units “kept food fresh on island bases and dropped into steaming jungle with parachute troops.” 

Fact Check: Did North Carolina Voting Sites Have Any Clusters of COVID-19 Cases?

Fact Check: Did North Carolina Voting Sites Have Any Clusters of COVID-19 Cases?

The Charlotte Observer, December 4, 2020

Karen Brinson Bell, executive director of the North Carolina State Board of Elections, said Nov. 24 that no spread of COVID-19 had been linked to voting in North Carolina. The NCSBE also said in a news release that there have been zero clusters of COVID-19 connected to voting sites in North Carolina. Are these claims accurate, and what counts as a “cluster”? Does that mean there weren’t any coronavirus cases connected to voting at all?

What's Driving Coronavirus Vaccine Hesitancy in US?

What's Driving Coronavirus Vaccine Hesitancy in US?

Fox News, December 3, 2020

The United States is potentially days away from approving the first round of coronavirus vaccines just nine months after the global pandemic ripped through every state, claimed hundreds of thousands of lives and crippled the once robust economy. And yet, millions have vowed not to take the fast-developed two-shot vaccines despite 95% efficacy rates from pharmaceutical companies Pfizer and BioNTech and another from Moderna. Why the hesitancy and how long could the COVID-19 crisis continue as a result?

States Craft Vaccine Plans in a Haze of Changing Information

States Craft Vaccine Plans in a Haze of Changing Information

Bloomberg Quint, December 4, 2020

Weeks before states expect to receive their first shipments of Covid-19 vaccines, conflicting messages from the federal government have obscured exactly how many doses may arrive. Some governors, including New York’s Andrew Cuomo and California’s Gavin Newsom, have made splashy announcements about how much of Pfizer Inc. and BioNTech SE’s vaccines they expect should the U.S. Food and Drug Administration authorize them this month. Other states can’t provide a solid answer given how quickly estimates change.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine